您即将离开沛嘉医疗中文官网。
您刚才点击了进入另一网站的链接。如果继续,您可能会进入由第三方运行的网站。 我们不负责对非沛嘉医疗中文官网上的内容进行审核与管控,亦不会对您在非沛嘉医疗中文网上的任何商业交易或事物承担任何责任。您使用其他网站时,必须遵循该网站的使用条款及隐私声明。 其他网站上的部分产品和信息可能并未在您所在地区或国家获得批准。
取消
继续
Brief News on Innovation
Company News Brief News on Innovation
First Patient Implant in the U.S. EFS for the GeminiOne TEER System
2026-04-10 13:30:31

In April, 2026, the first patient implant in the U.S. FDA Early Feasibility Study (“EFS”) for the GeminiOne Transcatheter Edge-to-Edge Repair (“TEER”) system has been successfully completed. The procedure was performed by Professor Saibal Kar, Director of Structural Heart Disease Interventions and Clinical Research at Los Robles Regional Medical Center (part of HCA Healthcare), and Clinical Professor of Medicine at the David Geffen School of Medicine at University of California, Los Angeles.



下一篇:没有了!
Top